Meeting of the National Advisory Council for Healthcare Research and Quality, 8427 [2023-02724]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 27 / Thursday, February 9, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services.
ACTION: Notice of public meeting.
AGENCY:
This notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality.
SUMMARY:
The meeting will be held on
Monday, March 6, 2023, from 11:30 a.m.
to 3:00 p.m.
ADDRESSES: The meeting will be held
virtually.
DATES:
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A,
Rockville, Maryland 20857, (301) 427–
1456. For press-related information,
please contact Bruce Seeman at (301)
427–1998 or Bruce.Seeman@
AHRQ.hhs.gov.
Closed captioning will be provided
during the meeting. If another
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
Monday, February 27, 2023. The
agenda, roster, and minutes will be
available from Jenny Griffith, Committee
Management Officer, Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Rockville, Maryland
20857. Jenny Griffith’s phone number is
(240) 446–6799.
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
I. Purpose
In accordance with section 10(a) of
the Federal Advisory Committee Act, 5
U.S.C. App., this notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality (the Council). The Council is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
VerDate Sep<11>2014
16:28 Feb 08, 2023
Jkt 259001
(B) the field of health care research
including training needs and
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
II. Agenda
On Monday, March 6, 2023, NAC
members will meet to conduct
preparatory work prior to convening the
Council meeting at 11:30 a.m., with the
call to order by the Council Chair, an
introduction of NAC members, and
approval of previous Council summary
notes. The NAC members will then
receive an update from the AHRQ
Director, including a follow up
discussion on private capital and
engaging health system executive
leadership. The agenda will also include
(1) an update and discussion by NAC
members on AHRQ’s Patient Safety
Framework and the Patient Safety
Action Alliance’s efforts to promote
Safer Together: A National Patient
Safety Action Plan and (2) a report out
and discussion about Long Covid and
addressing health system fragmentation.
The meeting is open to the public and
will adjourn at 3:00 p.m. For
information regarding how to access the
meeting as well as other meeting details,
including information on how to make
a public comment, please go to https://
www.ahrq.gov/news/events/nac/. The
final agenda will be available on the
AHRQ website no later than Monday
February 27, 2023.
Dated: February 3, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–02724 Filed 2–8–23; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[Docket No. ATSDR–2022–0006]
Availability of Four Draft Toxicological
Profiles
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
8427
(ATSDR), within the Department of
Health and Human Services (HHS),
announces the opening of a docket to
obtain comments on drafts of four
updated toxicological profiles: Cobalt,
Hexachlorocyclohexanes, 1,1,1Trichloroethane, and Vinyl Chloride.
Written comments must be
received on or before May 10, 2023.
DATES:
You may submit comments,
identified by Docket Number ATSDR–
2022–0006, by either of the following
methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Toxicology Section, Office of
Innovation and Analytics, Agency for
Toxic Substances and Disease Registry,
4770 Buford Highway, Mail Stop S102–
1, Atlanta, GA 30341–3717. Attn:
Docket No. ATSDR–2022–0006.
Instructions: All submissions must
include the Agency name and Docket
Number. All relevant comments
received will be posted without change
to www.regulations.gov, including any
personal information provided. Do not
submit comments by email. ATSDR
does not accept comments by email. For
access to the docket to read background
documents or comments received, go to
www.regulations.gov.
ADDRESSES:
N.
Roney, Agency for Toxic Substances
and Disease Registry, 4770 Buford
Highway, Mail Stop S102–1, Atlanta,
GA 30329–4027; Email:
ATSDRToxProfileFRNs@cdc.gov;
Telephone: 800–232–4636.
FOR FURTHER INFORMATION CONTACT:
ATSDR
has prepared drafts of four updated
toxicological profiles based on current
understanding of the health effects and
availability of new studies and other
information since their initial release.
All toxicological profiles issued as
‘‘Drafts for Public Comment’’ represent
the result of ATSDR’s evidence-based
evaluations to provide important
toxicological information on priority
hazardous substances to the public and
health professionals. ATSDR considers
key studies for these substances during
the profile development process, using
a systematic review approach. To that
end, ATSDR is seeking public
comments and additional information or
reports on studies about the health
effects of these four substances for
review and potential inclusion in the
profiles. ATSDR will evaluate the
quality and relevance of such data or
studies for possible inclusion in the
profile.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 88, Number 27 (Thursday, February 9, 2023)]
[Notices]
[Page 8427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02724]
[[Page 8427]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Meeting of the National Advisory Council for Healthcare Research
and Quality
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a meeting of the National Advisory
Council for Healthcare Research and Quality.
DATES: The meeting will be held on Monday, March 6, 2023, from 11:30
a.m. to 3:00 p.m.
ADDRESSES: The meeting will be held virtually.
FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management
Official, at the Agency for Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427-
1456. For press-related information, please contact Bruce Seeman at
(301) 427-1998 or [email protected].
Closed captioning will be provided during the meeting. If another
reasonable accommodation for a disability is needed, please contact the
Food and Drug Administration (FDA) Office of Equal Employment
Opportunity and Diversity Management on (301) 827-4840, no later than
Monday, February 27, 2023. The agenda, roster, and minutes will be
available from Jenny Griffith, Committee Management Officer, Agency for
Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland
20857. Jenny Griffith's phone number is (240) 446-6799.
SUPPLEMENTARY INFORMATION:
I. Purpose
In accordance with section 10(a) of the Federal Advisory Committee
Act, 5 U.S.C. App., this notice announces a meeting of the National
Advisory Council for Healthcare Research and Quality (the Council). The
Council is authorized by Section 941 of the Public Health Service Act,
42 U.S.C. 299c. In accordance with its statutory mandate, the Council
is to advise the Secretary of the Department of Health and Human
Services and the Director of AHRQ on matters related to AHRQ's conduct
of its mission including providing guidance on (A) priorities for
health care research, (B) the field of health care research including
training needs and information dissemination on health care quality and
(C) the role of the Agency in light of private sector activity and
opportunities for public private partnerships. The Council is composed
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.
II. Agenda
On Monday, March 6, 2023, NAC members will meet to conduct
preparatory work prior to convening the Council meeting at 11:30 a.m.,
with the call to order by the Council Chair, an introduction of NAC
members, and approval of previous Council summary notes. The NAC
members will then receive an update from the AHRQ Director, including a
follow up discussion on private capital and engaging health system
executive leadership. The agenda will also include (1) an update and
discussion by NAC members on AHRQ's Patient Safety Framework and the
Patient Safety Action Alliance's efforts to promote Safer Together: A
National Patient Safety Action Plan and (2) a report out and discussion
about Long Covid and addressing health system fragmentation. The
meeting is open to the public and will adjourn at 3:00 p.m. For
information regarding how to access the meeting as well as other
meeting details, including information on how to make a public comment,
please go to https://www.ahrq.gov/news/events/nac/. The final agenda
will be available on the AHRQ website no later than Monday February 27,
2023.
Dated: February 3, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-02724 Filed 2-8-23; 8:45 am]
BILLING CODE 4160-90-P
